Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice

Friedreich’s ataxia (FA) is an inherited neurodegenerative disorder caused by decreased expression of frataxin (FXN) protein. Previous studies have shown that antisense oligonucleotides (ASOs) and single-stranded silencing RNAs can be used to increase expression of frataxin in cultured patient-deriv...

Full description

Bibliographic Details
Main Authors: Audrius Kilikevicius, Jun Wang, Xiulong Shen, Frank Rigo, Thahza P. Prakash, Marek Napierala, David R. Corey
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:RNA Biology
Subjects:
Online Access:http://dx.doi.org/10.1080/15476286.2022.2043650
_version_ 1797403959750557696
author Audrius Kilikevicius
Jun Wang
Xiulong Shen
Frank Rigo
Thahza P. Prakash
Marek Napierala
David R. Corey
author_facet Audrius Kilikevicius
Jun Wang
Xiulong Shen
Frank Rigo
Thahza P. Prakash
Marek Napierala
David R. Corey
author_sort Audrius Kilikevicius
collection DOAJ
description Friedreich’s ataxia (FA) is an inherited neurodegenerative disorder caused by decreased expression of frataxin (FXN) protein. Previous studies have shown that antisense oligonucleotides (ASOs) and single-stranded silencing RNAs can be used to increase expression of frataxin in cultured patient-derived cells. In this study, we investigate the potential for oligonucleotides to increase frataxin expression in a mouse model for FA. After confirming successful in vivo delivery of oligonucleotides using a benchmark gapmer targeting the nuclear noncoding RNA Malat1, we tested anti-FXN oligonucleotides designed to function by various mechanisms. None of these strategies yielded enhanced expression of FXN in the model mice. Our inability to translate activation of FXN expression from cell culture to mice may be due to inadequate potency of our compounds or differences in the molecular mechanisms governing FXN gene repression and activation in FA model mice.
first_indexed 2024-03-09T02:47:12Z
format Article
id doaj.art-4663c9e0e133444eb5e6547471e2eb50
institution Directory Open Access Journal
issn 1547-6286
1555-8584
language English
last_indexed 2024-03-09T02:47:12Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series RNA Biology
spelling doaj.art-4663c9e0e133444eb5e6547471e2eb502023-12-05T16:09:51ZengTaylor & Francis GroupRNA Biology1547-62861555-85842022-12-0119136437210.1080/15476286.2022.20436502043650Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to miceAudrius Kilikevicius0Jun Wang1Xiulong Shen2Frank Rigo3Thahza P. Prakash4Marek Napierala5David R. Corey6UT Southwestern Medical CenterUniversity of Alabama at Birmingham, 1825 University BlvdUT Southwestern Medical CenterIonis Pharmaceuticals, Medicinal Chemistry and Antisense ResearchIonis Pharmaceuticals, Medicinal Chemistry and Antisense ResearchUniversity of Alabama at Birmingham, 1825 University BlvdUT Southwestern Medical CenterFriedreich’s ataxia (FA) is an inherited neurodegenerative disorder caused by decreased expression of frataxin (FXN) protein. Previous studies have shown that antisense oligonucleotides (ASOs) and single-stranded silencing RNAs can be used to increase expression of frataxin in cultured patient-derived cells. In this study, we investigate the potential for oligonucleotides to increase frataxin expression in a mouse model for FA. After confirming successful in vivo delivery of oligonucleotides using a benchmark gapmer targeting the nuclear noncoding RNA Malat1, we tested anti-FXN oligonucleotides designed to function by various mechanisms. None of these strategies yielded enhanced expression of FXN in the model mice. Our inability to translate activation of FXN expression from cell culture to mice may be due to inadequate potency of our compounds or differences in the molecular mechanisms governing FXN gene repression and activation in FA model mice.http://dx.doi.org/10.1080/15476286.2022.2043650friedrich’s ataxia; frataxin; antisense oligonucleotide; trinucleotide repeat
spellingShingle Audrius Kilikevicius
Jun Wang
Xiulong Shen
Frank Rigo
Thahza P. Prakash
Marek Napierala
David R. Corey
Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice
RNA Biology
friedrich’s ataxia; frataxin; antisense oligonucleotide; trinucleotide repeat
title Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice
title_full Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice
title_fullStr Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice
title_full_unstemmed Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice
title_short Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice
title_sort difficulties translating antisense mediated activation of frataxin expression from cell culture to mice
topic friedrich’s ataxia; frataxin; antisense oligonucleotide; trinucleotide repeat
url http://dx.doi.org/10.1080/15476286.2022.2043650
work_keys_str_mv AT audriuskilikevicius difficultiestranslatingantisensemediatedactivationoffrataxinexpressionfromcellculturetomice
AT junwang difficultiestranslatingantisensemediatedactivationoffrataxinexpressionfromcellculturetomice
AT xiulongshen difficultiestranslatingantisensemediatedactivationoffrataxinexpressionfromcellculturetomice
AT frankrigo difficultiestranslatingantisensemediatedactivationoffrataxinexpressionfromcellculturetomice
AT thahzapprakash difficultiestranslatingantisensemediatedactivationoffrataxinexpressionfromcellculturetomice
AT mareknapierala difficultiestranslatingantisensemediatedactivationoffrataxinexpressionfromcellculturetomice
AT davidrcorey difficultiestranslatingantisensemediatedactivationoffrataxinexpressionfromcellculturetomice